Jinmaitong decreases sciatic nerve DNA oxidative damage and apoptosis in a streptozotocin-induced diabetic rat model

Yin,De‑Hai; Liang,Xiao‑Chun; Zhao,Li; Zhang,Hong; Sun,Qing; Wang,Pu‑Yan; Sun,Lian‑Qing

doi:10.3892/etm.2015.2543

Jinmaitong decreases sciatic nerve DNA oxidative damage and apoptosis in a streptozotocin-induced diabetic rat model

Authors:
- De‑Hai Yin
- Xiao‑Chun Liang
- Li Zhao
- Hong Zhang
- Qing Sun
- Pu‑Yan Wang
- Lian‑Qing Sun
View Affiliations

Affiliations: Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Beijing 100032, P.R. China, Department of Nephrology and Endocrinology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, P.R. China, Cell Resource Center, School of Basic Medicine, Peking Union Medical College, Beijing 100005, P.R. China
Published online on: June 3, 2015 https://doi.org/10.3892/etm.2015.2543
Pages: 778-786

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic peripheral neuropathy (DPN) is a common chronic complication of diabetes. Jinmaitong (JMT), a Traditional Chinese Medicine, improves certain symptoms of DPN, such as limb pain and numbness. The aim of the present study was to investigate the effects of JMT on DNA oxidative damage and apoptosis in the sciatic nerve of diabetic rats. The rats were divided into a normal and a diabetic group. Diabetes was induced using streptozotocin (60 mg/kg). The diabetic model (DM) rats received vitamin C (0.05 g/kg/day) or JMT [low‑dosage (L), 0.44 g/kg/day; medium‑dosage (M), 0.88 g/kg/day or high‑dosage (H), 1.75 g/kg/day]. After 16 weeks, the mechanical pain threshold of the rats was evaluated. The expression of 8‑hydroxy‑deoxyguanosine (8‑OHdG), nicotinamide adenine dinucleotide phosphate (NADPH) oxidase p22phox, B‑cell lymphoma 2 (Bcl‑2), caspase 3 and cleaved‑poly(ADP‑ribose) polymerase 1 (PARP‑1) in the sciatic nerve tissues was measured using the reverse transcription‑quantitative polymerase chain reaction, immunohistochemistry and western blotting. JMT had no effect on body weight and fasting blood glucose levels. Following treatment, the rats in the JMT groups had an improved pain threshold compared with the DM controls (JMT‑L, 52.9±6.5 g; JMT‑M, 74.7±9.3 g; and JMT‑H, 61.7±2.0 g vs. DM control, 35.32±12.06 g; all P<0.01), while the threshold in the JMT‑M rats was similar to that of normal controls (P>0.05). 8‑OHdG and NADPH oxidase p22phox expression was significantly decreased in the three JMT groups compared with that in the DM controls (all P<0.05). Following JMT treatment, Bcl‑2 levels were increased, while caspase 3 and cleaved‑PARP‑1 levels were decreased compared with those in the DM controls (all P<0.01). In conclusion, JMT may reduce DNA oxidative damage to the sciatic nerve in diabetic rats, as well as regulate genes involved in peripheral neuronal cell apoptosis, suggesting that JMT could be used to prevent or treat DPN in diabetic patients.

View Figures

View References

1	Dobretsov M, Romanovsky D and Stimers JR: Early diabetic neuropathy: Triggers and mechanisms. World J Gastroenterol. 13:175–191. 2007. View Article : Google Scholar : PubMed/NCBI
2	Dyck PJ, Kratz KM, Karnes JL, et al: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology. 43:817–824. 1993. View Article : Google Scholar : PubMed/NCBI
3	Tesfaye S: Advances in the management of diabetic peripheral neuropathy. Curr Opin Support Palliat Care. 3:136–143. 2009. View Article : Google Scholar : PubMed/NCBI
4	Edwards JL, Vincent AM, Cheng HT and Feldman EL: Diabetic neuropathy: Mechanisms to management. Pharmacol Ther. 120:1–34. 2008. View Article : Google Scholar : PubMed/NCBI
5	Genuth S: Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr Pract. 12 Suppl:1:34–41. 2006. View Article : Google Scholar
6	Vinik A, Emir B, Cheung R and Whalen E: Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin. Clin Ther. 35:612–623. 2013. View Article : Google Scholar : PubMed/NCBI
7	Nicholson B: Differential diagnosis: Nociceptive and neuropathic pain. Am J Manag Care. 12 (Suppl):S256–S262. 2006.PubMed/NCBI
8	Shakher J and Stevens MJ: Update on the management of diabetic polyneuropathies. Diabetes Metab Syndr Obes. 4:289–305. 2011.PubMed/NCBI
9	Russell JW, Sullivan KA, Windebank AJ, Herrmann DN and Feldman EL: Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis. 6:347–363. 1999. View Article : Google Scholar : PubMed/NCBI
10	Allen DA, Yaqoob MM and Harwood SM: Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem. 16:705–713. 2005. View Article : Google Scholar : PubMed/NCBI
11	El Boghdady NA and Badr GA: Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy. Cell Biochem Funct. 30:328–334. 2012. View Article : Google Scholar : PubMed/NCBI
12	Figueroa-Romero C, Sadidi M and Feldman EL: Mechanisms of disease: The oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 9:301–314. 2008. View Article : Google Scholar : PubMed/NCBI
13	Kasznicki J, Kosmalski M, Sliwinska A, et al: Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy. Mol Biol Rep. 39:8669–8678. 2012. View Article : Google Scholar : PubMed/NCBI
14	Schmeichel AM, Schmelzer JD and Low PA: Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes. 52:165–171. 2003. View Article : Google Scholar : PubMed/NCBI
15	Sun LQ, Zhao J, Zhang TT, et al: Protective effects of Salvianolic acid B on Schwann cells apoptosis induced by high glucose. Neurochem Res. 37:996–1010. 2012. View Article : Google Scholar : PubMed/NCBI
16	Hernández-Beltrán N, Moreno CB and Gutiérrez-Álvarez AM: Contribution of mitochondria to pain in diabetic neuropathy. Endocrinol Nutr. 60:25–32. 2013. View Article : Google Scholar : PubMed/NCBI
17	Piao Y and Liang X: Chinese medicine in diabetic peripheral neuropathy: Experimental research on nerve repair and regeneration. Evid Based Complement Alternat Med. 2012:1916322012. View Article : Google Scholar : PubMed/NCBI
18	Shi Y, Liang XC, Wu QL, et al: Effects of Jinmaitong Capsule on ciliary neurotrophic factor in sciatic nerves of diabetes mellitus rats. Chin J Integr Med. 19:104–111. 2013. View Article : Google Scholar : PubMed/NCBI
19	Qu L, Liang XC, Zhang H, Wu QL, Sun LQ and Gu B: Effect of Jinmaitong serum on the proliferation of rat Schwann cells cultured in high glucose medium. Chin J Integr Med. 14:293–297. 2008. View Article : Google Scholar : PubMed/NCBI
20	Kim J, Yokoyama K and Araki S: The effects of Ginkgo biloba extract (GBe) on axonal transport microvasculature and morphology of sciatic nerve in streptozotocin-induced diabetic rats. Environ Health Prev Med. 5:53–59. 2000. View Article : Google Scholar : PubMed/NCBI
21	Varvarovská J, Racek J, Stetina R, et al: Aspects of oxidative stress in children with type 1 diabetes mellitus. Biomed Pharmacother. 58:539–545. 2004. View Article : Google Scholar : PubMed/NCBI
22	Pop-Busui R, Sima A and Stevens M: Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev. 22:257–273. 2006. View Article : Google Scholar : PubMed/NCBI
23	Bedard K and Krause KH: The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev. 87:245–313. 2007. View Article : Google Scholar : PubMed/NCBI
24	Toyokuni S: Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int. 49:91–102. 1999. View Article : Google Scholar : PubMed/NCBI
25	Obrosova IG, Xu W, Lyzogubov VV, et al: PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic Biol Med. 44:972–981. 2008. View Article : Google Scholar : PubMed/NCBI
26	Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G and Murcia JM: Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem. 273:33533–33539. 1998. View Article : Google Scholar : PubMed/NCBI
27	Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T and Vandenabeele P: Caspases in cell survival, proliferation and differentiation. Cell Death Differ. 14:44–55. 2007. View Article : Google Scholar : PubMed/NCBI
28	Qin W, Hu J, Guo M, et al: BNIPL-2, a novel homologue of BNIP-2, interacts with Bcl-2 and Cdc42GAP in apoptosis. Biochem Biophys Res Commun. 308:379–385. 2003. View Article : Google Scholar : PubMed/NCBI
29	Fuchs D, Birklein F, Reeh PW and Sauer SK: Sensitized peripheral nociception in experimental diabetes of the rat. Pain. 151:496–505. 2010. View Article : Google Scholar : PubMed/NCBI
30	Dobretsov M, Hastings SL, Romanovsky D, Stimers JR and Zhang JM: Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res. 960:174–183. 2003. View Article : Google Scholar : PubMed/NCBI
31	Vivancos GG, Verri WA Jr, Cunha TM, et al: An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res. 37:391–399. 2004. View Article : Google Scholar : PubMed/NCBI
32	Chaplan SR, Bach FW, Pogrel JW, Chung JM and Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:55–63. 1994. View Article : Google Scholar : PubMed/NCBI
33	Farghaly HS, Abd-Ellatief RB, Moftah MZ, Mostafa MG, Khedr EM and Kotb HI: The effects of dexmedetomidine alone and in combination with tramadol or amitriptyline in a neuropathic pain model. Pain Physician. 17:187–195. 2014.PubMed/NCBI
34	Wang PY, Liang XC, Zhang H, et al: Effect of serum containing Jinmaitong Capsule on rats' Schwann cell apoptosis induced by high glucose concentration. Chin J Integr Med. 19:517–523. 2013. View Article : Google Scholar : PubMed/NCBI
35	Pazdro R and Burgess JR: The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev. 131:276–286. 2010. View Article : Google Scholar : PubMed/NCBI
36	Vincent AM, Edwards JL, Sadidi M and Feldman EL: The antioxidant response as a drug target in diabetic neuropathy. Curr Drug Targets. 9:94–100. 2008. View Article : Google Scholar : PubMed/NCBI
37	Ji JL and Chen DS: Experiment study of nourishing yin, invigorating qi, extinguishing wind, promoting blood circulation and draining collateral method of the sciatic nerve Schwann cells apoptosis of diabetic rats. Zhongguo Zhong Yi Ji Zheng. 18:1304–1306. 2009.(In Chinese).
38	Liu XY, Zhang YY and Zhang JQ: Effect of astragalus, salvia, yam and its compound on apoptosis of Schwann cells co-cultured with endothelial cells in high glucose. Zhong Yao Yao Li Yu Lin Chuang. 26:41–44. 2010.(In Chinese).